お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
944520

無針注射システムの世界市場: 動向、予測、競合分析

Needle Free Injection System Market Report: Trends, Forecast and Competitive Analysis

出版日: 受注後作成 | 発行: Lucintel | ページ情報: 英文 | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.20円

【セミカスタムオーダー型の調査レポート】
当レポートは、目次内の調査項目について *追加/変更ご要望を反映させる事も可能です。
* ご要望が無い場合は目次通りの内容構成にて作成となります。
* ご要望項目の分量によりましては追加費用が発生する場合がございます。

無針注射システムの世界市場: 動向、予測、競合分析
出版日: 受注後作成
発行: Lucintel
ページ情報: 英文
納期: お問合せ
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の無針注射システム市場は、2019年から2024年にかけて16%のCAGRで成長を続ける見通しです。市場拡大の主な原動力となるのは、病院や診療所、在宅医療、研究機関、製薬会社、バイオテクノロジー企業などでの市場機会、慢性疾患の有病率の増加、針刺し事故による感染症発生率の増加、自己注射器の需要拡大などの要因です。

当レポートは、世界の無針注射システム市場を調査したもので、これまでのトレンドと今後の予測、各地域市場の分析、競合情勢の分析、成長機会と戦略的な分析、主要企業のプロファイルなどの情報を提供しています。

第1章 エグゼクティブサマリー

第2章 市場の背景と分類

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の成長促進要因と課題

第3章 市場の動向と予測分析:2013年~2024年

  • マクロ経済の動向と予測
  • 世界市場の動向と予測
  • 製品タイプ市場
    • 薬剤充填型
    • 薬剤充填済み
  • 技術別市場
    • ジェットベース
    • スプリングベース
    • レーザー式
    • 振動ベース
  • 利用形態別市場
    • 再利用可能
    • 使い捨て
  • 薬の種類別市場
    • 液体ベース
    • 粉末ベース
    • 発射体/デポベース
  • 投与部位別
    • 皮内注射器
    • 筋肉内注射器
    • 皮下注射器
  • 用途別市場
    • ワクチン送達
    • インスリン送達
    • 疼痛管理薬送達
    • 腫瘍治療薬送達
    • その他
  • エンドユーザー別市場
    • 病院、診療所
    • 在宅介護
    • 研究機関
    • 製薬会社、バイオテクノロジー企業
    • その他

第4章 各地域市場の動向と予測分析

  • 地域別市場
  • 北米
  • 欧州
  • アジア太平洋
  • その他

第5章 競合情勢の分析

  • 製品ポートフォリオ分析
  • 市場シェア分析
  • 業務統合
  • 事業展開している地域
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
  • 市場の新たなトレンド
  • 戦略的分析
    • 新製品の開発
    • 市場拡大
    • 合併、買収、合弁事業

第7章 主要企業のプロファイル

  • Antares Pharma
  • Endo International
  • Pharmajet
  • Bioject Medical Technologies
  • Medical International Technology
  • Injex Pharma
  • National Medical Products
  • Valeritas
  • European Pharma Group
  • Penject Corporation
目次

The future of the needle free injection system market looks promising with opportunities in the hospitals and clinics, homecare settings, research laboratories, pharmaceutical and biotechnology companies. The global needle free injection system market is expected to grow with a CAGR of 16% from 2019 to 2024. The major drivers for this market are growing prevalence of chronic diseases, increasing incidence of communicable diseases due to needle stick injuries, and rise in demand for self-injection devices.

A report of more than 150 pages is developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of needle free injection system market report download the report brochure

The study includes the needle free injection system market size and forecast for the global needle free injection system market through 2024, segmented by product, technology, usability, site of delivery, type of medication, application, end user, and region as follows:

By Product [$M shipment analysis for 2013 - 2024]:

  • Fillable Needle-Free Injectors
  • Prefilled Needle-Free Injectors

By Technology [$M shipment analysis for 2013 - 2024]:

  • Jet-Based Needle-Free Injectors
  • Spring-Based Needle-Free Injectors
  • Laser-Powered Needle-Free Injectors
  • Vibration-Based Needle-Free Injectors

By Usability [$M shipment analysis for 2013 - 2024]:

  • Reusable Needle-Free Injectors
  • Disposable Needle-Free Injectors

By Type of Medication [$M shipment analysis for 2013 - 2024]:

  • Liquid-based needle free injectors
  • Powder-based needle free injectors
  • Projectile/depot-based needle free injectors

By Site of Delivery [$M shipment analysis for 2013 - 2024]:

  • Intra dermal injectors
  • Intramuscular injectors
  • Subcutaneous injectors

By Application [$M shipment analysis for 2013 - 2024]:

  • Vaccine Needle free delivery
  • Insulin Needle free delivery
  • Pain Management Needle free delivery
  • Oncology Needle free delivery
  • Others

By End User [$M shipment analysis for 2013 - 2024]:

  • Hospitals and Clinics
  • Homecare Settings
  • Research Laboratories
  • Pharmaceutical and Biotechnology companies
  • Others

By Region [$M shipment analysis for 2013 - 2024]:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
  • Rest of the World (ROW)
    • Brazil

Some of the needle free injection system companies profiled in this report includes Antares Pharma, Endo, Pharmajet, Bioject Medical Technologies, Medical International Technology, Injex Pharma, National Medical Products, Valeritas, European Pharma Group, Penject, and Crossject.

Some of the features of "Global Needle Free Injection System Market 2019-2024: Trends, Forecast, and Opportunity Analysis" includes

  • Market size estimates:Global needle free injection system market size estimation in terms of value ($M) shipment.
  • Trend and forecast analysis: Market trend (2013-2018) and forecast (2019-2024) by segments and region.
  • Segmentation analysis:Global market size by product, technology, usability, site of delivery, type of medication, application, end user, and region.
  • Regional analysis:Global needle free injection system market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth opportunities:Analysis on growth opportunities in different applications and regions for needle free injection system in the global needle free injection system market.
  • Strategic analysis:This includes M&A, new product development, and competitive landscape for ,needle free injection system in the global needle free injection system market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising potential, high-growth opportunities for the global needle free injection system market by product (fillable needle-free injectors, prefilled needle-free injectors), technology (jet-based needle-free injectors, spring-based needle-free injectors, laser-powered needle-free injectors, vibration-based needle-free injectors), usability (reusable needle-free injectors, disposable needle-free injectors), type of medication (liquid-based needle free injectors, powder-based needle free injectors, projectile/depot-based needle free injectors), site of delivery (intra dermal injectors, intramuscular injectors, subcutaneous injectors, application (vaccine needle free delivery, insulin needle free delivery, pain management needle free delivery, oncology needle free delivery and others), end user (hospitals and clinics, homecare settings, research laboratories, pharmaceutical and biotechnology companies and others), and region (North America, Europe, Asia-pacific, Rest of the World (ROW)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which regions will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the needle free injection system market?
  • Q.5. What are the business risks and threats to the needle free injection system market?
  • Q.6. What are emerging trends in this needle free injection system market and the reasons behind them?
  • Q.7. What are some changing demands of customers in the needle free injection System market?
  • Q.8. What are the new developments in the needle free injection system market? Which companies are leading these developments?
  • Q.9. Who are the major players in this needle free injection system market? What strategic initiatives are being implemented by key players for business growth?
  • Q.10. What are some of the competitive products and processes in this needle free injection system area and how big of a threat do they pose for loss of market share via material or product substitution?
  • Q.11.What M & A activities have taken place in the last 5 years in this,needle free injection system market?

1. Executive Summary

2. Market Background and Classifications

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2013 to 2024

  • 3.1: Macroeconomic Trends and Forecast
  • 3.2: Global needle free injection systems Market: Trends and Forecast
  • 3.3: Global needle free injection systems Market by Product Type
    • 3.3.1: Fillable Needle-Free Injector
    • 3.3.2: Prefilled Needle-Free Injectors
  • 3.4: Global needle free injection systems Market by Technology
    • 3.4.1: Jet-Based Needle-Free Injectors
    • 3.4.2: Spring-Based Needle-Free Injectors
    • 3.4.3: Laser-Powered Needle-Free Injectors
    • 3.4.4: Vibration-Based Needle-Free Injectors
  • 3.5: Global needle free injection systems Market by Usability
    • 3.5.1: Reusable Needle-Free Injectors
    • 3.5.2: Disposable Needle-Free Injectors
  • 3.6: Global needle free injection systems Market by Type of Medication
    • 3.6.1: Liquid-based needle free injectors
    • 3.6.2: Powder-based needle free injectors
    • 3.6.3: Projectile/depot-based needle free injectors
  • 3.7: Global needle free injection systems Market by Site of Delivery
    • 3.7.1: Intra dermal injectors
    • 3.7.2: Intramuscular injectors
    • 3.7.3: Subcutaneous injectors
  • 3.8: Global needle free injection systems Market by Application
    • 3.8.1: Vaccine Needle free delivery
    • 3.8.2: Insulin Needle free delivery
    • 3.8.3: Pain Management Needle free delivery
    • 3.8.4: Oncology Needle free delivery
    • 3.8.5: Others
  • 3.9: Global needle free injection systems Market by End Use Industry
    • 3.9.1: hospitals and clinics
    • 3.9.2: homecare settings
    • 3.9.3: research laboratories
    • 3.9.4: pharmaceutical and biotechnology companies
    • 3.9.5: other end user

4. Market Trends and Forecast Analysis by Region

  • 4.1: Global needle free injection systems Market by Region
  • 4.2: North American needle free injection systems Market
    • 4.2.1: Market by End Use Industry: Hospitals And Clinics, Homecare Settings, Research Laboratories, Pharmaceutical and Biotechnology Companies, and Other End User
  • 4.3: European needle free injection systems Market
    • 4.3.1: Market by End Use Industry: Hospitals And Clinics, Homecare Settings, Research Laboratories, Pharmaceutical and Biotechnology Companies, and Other End User
  • 4.4: APAC needle free injection systems Market
    • 4.4.1: Market by End Use Industry: Hospitals And Clinics, Homecare Settings, Research Laboratories, Pharmaceutical and Biotechnology Companies, and Other End User
  • 4.5: ROW needle free injection systems Market
    • 4.5.1: Market by End Use Industry: Hospitals And Clinics, Homecare Settings, Research Laboratories, Pharmaceutical and Biotechnology Companies, and Other End User

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Market Share Analysis
  • 5.3: Operational Integration
  • 5.4: Geographical Reach
  • 5.5: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for Global needle freeinjection systems Market by Product
    • 6.1.2: Growth Opportunities for Global Market by Technology
    • 6.1.3: Growth Opportunities for Global Market by Usability
    • 6.1.4: Growth Opportunities for Global Market by Site of Delivery
    • 6.1.5: Growth Opportunities for Global Market by Type of Medication
    • 6.1.6: Growth Opportunities for Global Market by Application
    • 6.1.7: Growth Opportunities for Global needle free injection systems Market by End Use Industry
    • 6.1.8: Growth Opportunities for Global needle free injection systems Market by Region
  • 6.2: Emerging Trends in Global needle free injection systems Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of Global needle free injection systems Market
    • 6.3.3: Mergers, Acquisitions and Joint Ventures in the Global Market

7. Company Profiles of Leading Players

  • 7.1: Antares Pharma
  • 7.2: Endo International
  • 7.3: Pharmajet
  • 7.4: Bioject Medical Technologies
  • 7.5: Medical International Technology
  • 7.6: Injex Pharma
  • 7.7: National Medical Products
  • 7.8: Valeritas
  • 7.9: European Pharma Group
  • 7.10:Penject Corporation
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.